Mutually exclusive alterations affecting the MAPK pathway (BRAF, KRAS, NRAS) are observed more frequently than in EATL, collectively in about 80% of cases [46, 52]. The gene discussed is NRAS; the disease is enteropathy-associated T-cell lymphoma.